Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04474470 |
Title | A Study to Evaluate NT219 Alone and in Combination With ERBITUX (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | TyrNovo Ltd. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ISR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
California Cancer Associates for Research and Excellence | Encinitas | California | 92024 | United States | Details | |
The Angeles Clinic and Research Institute | Los Angeles | California | 90025 | United States | Details | |
UCSD Moores Cancer Center | San Diego | California | 92037 | United States | Details | |
MedStar Georgetown University Hospital | Washington, D.C. | District of Columbia | 20007 | United States | Details | |
The University of Chicago and Biological Sciences | Chicago | Illinois | 60637 | United States | Details | |
Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | United States | Details | |
Stephenson Cancer Center | Oklahoma City | Oklahoma | 73117 | United States | Details | |
Hadassah University Medical Center | Jerusalem | Israel | Details | |||
Rabin Medical Center | Petah tikva | Israel | Details | |||
Sourasky Medical Center | Tel Aviv | Israel | Details |